Search Results 181-190 of 17419 for Mmol

1. A Study to Evaluate Effectiveness of Preventing Urinary Stones With Hydration - Mayo Clinic

   History or presence of hyponatremia (serum sodium <130 mmol/L) or hypo‐osmolality (serum osmolality <275 mosm/kg). Study participants with comorbidities ...

2. Oatd-01, an Oral Inhibitor of Chitinase-1 (CHIT1), for the Treatment of Active Pulmonary Sarcoidosis - Mayo Clinic

   ... mmol/L), marked fasting hyperglycemia at screening; Uncontrolled diabetes at Screening with plasma glucose exceeding 8.3 mmol/L, or other contraindication to ...

3. A Study to Evaluate Gemcitabine in Patients Undergoing Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma - Mayo Clinic

   Creatinine < 2.2 mg/dL (194 mmol/L);; Adequate hematologic function (hemoglobin > 9 g/dL; white blood cell count ≥ 3000/μL; platelet count >75,000/μL and ...

4. Clinical Trials - INcrease Of VAgal TonE in CHF

   Severe hepatic failure (transaminase level four times ULN, or total bilirubin level > 1.8 mmol/dL). Uncontrolled Diabetes Mellitus, which in the opinion of ...

5. Gadobutrol (intravenous route) - Mayo Clinic

   Gadobutrol injection is a magnetic resonance imaging (MRI) contrast agent that is used to help create a clear picture of the body during an MRI scan. MRI scans ...

6. A Phase 1 Study Evaluating the Safety, PK, and Clinical Effects of PT-112 in Subjects With Advanced Solid Tumors

   Fasting plasma glucose ≤ 120 mg/dL (6.7 mmol/L);; HbA1c ≤ 8%;. Negative serum pregnancy test within 72 hours before starting study treatment in women with ...

7. Safety and Immunogenicity of PolyPEPI1018 Vaccine in the Treatment of Metastatic Colorectal Cancer (OBERTO) - Mayo Clinic

   Platelets ≥100 × 109/L, hemoglobin ≥5.6 mmol/L (corresponding to 9 g/dL). Serum bilirubin ≤1.5 × upper limit of normal (ULN) set by the site. Alanine ...

8. A Study to Evaluate Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients with Chronic Myeloid Leukemia and Persistently- Detectable Minimal Residual Disease - Mayo Clinic

   Hgb ≥ 9.0 g/dL OR ≥ 5.6 mmol/L without transfusion of EPO dependency. Hgb:______ Date of Test:______. Serum creatinine ≤ 1.5 X upper limit of ...

9. Study Of Efficacy And Safety Of LNP023 In Primary IgA Nephropathy Patients - Mayo Clinic

   ... mmol) sampled from FMV or 24h urine collection, as well as at the completion of the run-in period by UPCR ≥1 g/g (113 mg/mmol) calculated as the (geometric) ...

10. A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma (GOLSEEK-2) - Mayo Clinic

    Hemoglobin < 10g/dL (6.25 mmol/L). v) Pleural or peritoneal serous effusion (irrespective of cell content). vi) Any compressive syndrome (for example, but ...